A trio of tiny biotech firms have announced plans to invest up to $1 million in Bitcoin. They are not the next MicroStrategy.

MicroStrategy is severely overvalued with a 150% premium over Bitcoin. Learn why MSTR stock is a Sell and direct Bitcoin purchases or ETFs are better alternatives.

One of the more impressive runs higher ever seen in stocks took at least a brief breather on Thursday, with Bitcoin Development Company MicroStrategy (MSTR) sporting a double-digit percentage loss even as the price of bitcoin {{BTC}} surged to a new record high just shy of $100,

MicroStrategy stock is up more than fivefold in 2024 thanks to a furious rally in bitcoin. Here's what you need to know.

MicroStrategy shares rocketed higher again Wednesday, as the largest corporate holder of bitcoin reaps the benefits of record-high prices for the cryptocurrency.

Explore how MicroStrategy's $42 billion debt-driven Bitcoin strategy could impact BTC prices and whether it's sustainable long-term.

Citron Research has taken a short position in MicroStrategy , the company said in a post on social media platform X on Thursday.

MicroStrategy’s stock surges toward a fourth-straight record, and fourth-straight double-digit gain, as bitcoin continues march toward $100K.

MicroStrategy shares plummeted sharply lower on Thursday after Citron Research said it shorted the stock against a long position in Bitcoin. “Much respect to @saylor, but even he must know $MSTR is overheated,

The company has attracted attention for a huge—many would say reckless— one-way bet on bitcoin, which it started buying and holding in 2020. Co-founder and Executive Chairman Michael Saylor has become a bitcoin evangelist.